These compounded versions arent the same and may act differently in the body than the FDA-approved semaglutide and tirzepatide and, thus, cause harm. Semaglutides can help with weight loss, but they shouldnt be used for short-term weight loss
A large 2023 study including people without diabetes who were using GLP-1 agonists for weight loss found that this class of medications may increase the risk of gastrointestinal conditions, such as gastroparesis
Effects of warfarin and L-carnitine on hemostatic function and oxidative stress in streptozotocin-induced diabetic rats
If youre deciding between delivery methods, this breakdown of nasal spray versus injections for peptides covers the bioavailability tradeoffs across routes that also apply to antioxidant compounds
Weight Loss Care, Personalized to You Connect with a provider who can help determine whether GLP-1 treatment is right for you, then get ongoing support to stay on track